Owlet (OWLT) Stock News

Owlet (NYSE:OWLT), a smart infant monitoring technology company, has received Therapeutic Goods Administration (TGA) certification for its Dream Sock™ device in Australia and New Zealand. The Dream Sock is a wearable smart baby monitor designed for infants aged 0-18 months that tracks vital health indicators including pulse rate, oxygen level, and sleep patterns.

The certification paves the way for Owlet's expansion in these markets, with the product expected to launch later in 2025 through the company's website and retail partners like Baby Bunting. The device, which has already monitored over 2 million babies globally, provides real-time health data through the Owlet Dream App and Base Station.

Owlet (NYSE:OWLT) reported strong Q2 2025 financial results, with revenue reaching $26.1 million, up 25.9% year-over-year. The company achieved a gross margin of 51.3%, improving 180 basis points from Q2 2024. Despite posting a net loss of $37.6 million (including a $34.8 million non-cash warrant adjustment), Owlet delivered positive Adjusted EBITDA of $0.3 million.

The company announced a significant leadership change, with President Jonathan Harris succeeding founder Kurt Workman as CEO effective October 1, 2025. Workman will transition to Executive Chairman. Additionally, Owlet raised its full-year 2025 guidance, now expecting revenue between $97-100 million (24-28% growth) and projecting full-year adjusted EBITDA profitability.

Owlet's subscription service Owlet360 showed strong momentum, surpassing 66,000 paying subscribers with improvements in monthly recurring revenue, attach rate, and retention.

Owlet (NYSE:OWLT), a smart infant monitoring company, has announced a significant warrant exchange agreement to simplify its capital structure. The company will issue 5,426,429 shares of common stock in exchange for approximately 96% of Series A warrants (7,215,737) and all Series B warrants (1,799,021).

Key participants include Eclipse Ventures LLC, Trilogy Equity Partners, CEO Kurt Workman, and board member John Kim, collectively representing 43% voting power. The exchanged shares will be subject to a 180-day lockup period. The transaction requires stockholder approval and customary closing conditions.

Owlet (NYSE:OWLT) has scheduled its second quarter 2025 financial results announcement for August 7, 2025, after market close. The company will host a conference call at 4:30 p.m. ET featuring CEO Kurt Workman, President Jonathan Harris, and CFO Amanda Twede Crawford.

Investors can join via phone using the numbers 833-470-1428 (domestic) or 404-975-4839 (international) with access code 579904. A simultaneous webcast will be available on Owlet's Investor Relations website, with a replay accessible shortly after the call.

Owlet (NYSE: OWLT), a smart infant monitoring company, has donated 250 FDA-cleared Dream Sock monitors (valued at $75,000) to March of Dimes' NICU Care Package Kit program. The donation comes as NICU admissions have increased 13% in less than a decade. The Dream Sock monitors will be distributed across Boston area hospitals, with Boston Medical Center receiving one-fifth of the donation. The Dream Sock is the first FDA-cleared smart baby monitor that tracks vital signs like pulse rate and oxygen saturation, having monitored over 2 million babies globally. The device sends live health readings to parents' mobile devices through the Owlet Dream App. Additionally, Owlet will participate in the March for Babies walk in Cleveland on May 17th, sponsoring the Honor Tent and distributing Nursery of Hope seedlings. Through various charitable initiatives, Owlet has reached $1.9 million in donations and partnered with 37 non-profit organizations globally.

Owlet (NYSE:OWLT) reported strong Q1 2025 financial results with revenue of $21.1 million, up 43.1% year-over-year. The company achieved a gross margin of 53.7%, improving 930 basis points from Q1 2024. Net income was $3.0 million, slightly down from $3.3 million in Q1 2024, while Adjusted EBITDA reached breakeven, improving by $3.1 million compared to Q1 2024. The growth was primarily driven by higher sales of Dream Sock and Dream Duo products, along with the success of Owlet360 subscription service, which now has over 48,000 paying subscribers. The company updated its 2025 outlook, projecting revenue between $91-95 million (17-22% growth) and gross margins of 46-50%. Owlet also announced a new distribution partnership with Children's Hospital of The King's Daughters, marking the first time babies can leave the hospital with BabySat or Dream Sock products.

Owlet (NYSE: OWLT) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8, 2025. The company will host a conference call at 4:30 p.m. ET featuring CEO and Co-Founder Kurt Workman, President Jonathan Harris, and CFO Amanda Twede Crawford to discuss the results and provide a business update.

Investors can join the call using the following dial-in numbers: 833-470-1428 (domestic) or 404-975-4839 (international) with Access Code 952382. A simultaneous webcast will be available through the Events section of Owlet's Investor Relations website, with a replay accessible shortly after the call concludes.

Owlet (NYSE:OWLT) reported its Q4 and full year 2024 financial results, marking its strongest financial performance in company history. Q4 revenue reached $20.5M with a gross margin of 53.5%, while posting a net loss of $9.1M. The quarter showed a 37% revenue growth compared to Q4 2023, excluding prior year Amazon distribution impact.

Full year 2024 highlights include revenue of $78.1M (up 45% from 2023), improved gross margin of 50.4% (up 850 basis points), and reduced net loss of $12.5M (compared to $32.9M in 2023). The company achieved significant milestones, including launching the first FDA-cleared baby monitoring device and expanding internationally.

Looking ahead to 2025, Owlet projects revenue between $88M-$92M, targeting gross margins of 50-52%, and aims for adjusted EBITDA profitability. The company recently launched Owlet360, a new subscription service providing personalized pediatric health insights.

Owlet (NYSE: OWLT), the pioneer in smart infant monitoring, has announced its participation in TD Cowen's 45th Annual Health Care Conference. The event will take place on March 5, 2025, at the Boston Marriott Copley Place.

The company's leadership team, including CEO and Co-Founder Kurt Workman, President and CRO Jonathan Harris, and CFO Amanda Twede-Crawford, will participate in a fireside chat scheduled for 9:50 a.m. ET. Investors can access the live webcast through Owlet's Investor Relations website at investors.owletcare.com, where a replay will also be available after the event.